Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
corruption
Pharma
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Eisai initiated a U.S. restructuring program. A former China NMPA deputy director is under investigation. Pfizer formed a collaboration with Summit.
Angus Liu
Feb 28, 2025 8:45am
Embattled Insys will pay $225M to wrap Subsys kickback probe
Jun 6, 2019 10:39am
Thanks, Kangmei. China's probing 77 pharmas—including Lilly, BMS
Jun 4, 2019 10:50am
Opioid trial: J&J 'brainwashing,' leaked Sackler depo, and more
May 29, 2019 11:45am
Novartis bribery case nears collapse after 4 officials cleared
Apr 9, 2019 11:16am
45 Chinese vaccine makers cleared in sweeping inspections
Sep 10, 2018 10:35am
